Literature DB >> 10492411

Patients with poor preoperative ejection fraction have a higher plasma response of adrenomedullin in response to open heart surgery.

J A Amado1, I Fidalgo, M T García-Unzueta, C Montalbán, I Del Moral, F Pazos, C Diago.   

Abstract

BACKGROUND: Adrenomedullin (AM) is a potent vasodilator peptide. Plasma AM levels are increased in heart diseases and in sepsis. Heart surgery under cardiopulmonary bypass (CPB) induces a systemic inflammatory response.
METHODS: We measured plasma AM, cAMP (the second messenger of AM), C-reactive protein (CRP) and haemodynamic parameters in 29 patients undergoing elective open heart surgery, before, during and after anaesthesia and CPB as well as on the first morning after surgery.
RESULTS: Basal AM levels were higher than normal and correlated with systolic pulmonary pressure and pulmonary capillary pressure, but not with other haemodynamic parameters. AM increased during CPB and remained elevated 24 h after the start of surgery. Plasma cAMP increased only at the end of CPB. CRP was increased only in the last sample. At the end of CPB and at the end of surgery AM levels were higher in patients with basal ejection fraction<40% compared with those with ejection fraction >60% [456+/-386 vs 252+/-343 (P<0.03) and 832+/-781 vs 391+/-356 pg/ml (P<0.05), respectively].
CONCLUSION: We conclude that AM, as inflammation-related cytokines, increases during and after CPB, that cAMP response is unrelated to AM and that AM response is higher in those patients with worse basal ejection fraction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492411     DOI: 10.1034/j.1399-6576.1999.430808.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.

Authors:  Artur Świerczek; Elżbieta Wyska; Sebastian Baś; Marta Woyciechowska; Jacek Mlynarski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-20       Impact factor: 3.000

2.  Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study.

Authors:  Sara Bobillo-Perez; Iolanda Jordan; Patricia Corniero; Monica Balaguer; Anna Sole-Ribalta; Maria Esther Esteban; Elisabeth Esteban; Francisco Jose Cambra
Journal:  PLoS One       Date:  2019-06-17       Impact factor: 3.240

3.  Protective Effects of Adrenomedullin on Rat Cerebral Tissue After Transient Bilateral Common Carotid Artery Occlusion and Reperfusion.

Authors:  Mehmet Kirişci; Hakan Gunes; Aydemir Kocarslan; Tuba Ozcan Metin; Duygun Altintas Aykan; Muhammed Seyithanoglu; Adem Doganer; Gulsen Bayrak; Ekrem Aksu
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.